Product
Placebo matching IMU-838
2 clinical trials
1 indication
Indication
Multiple SclerosisClinical trial
A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 Versus Placebo in Adults With Relapsing Multiple Sclerosis (ENSURE-1)Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple SclerosisStatus: Active (not recruiting), Estimated PCD: 2025-01-07